ROSUVASTATIN CALCIUM NANOSPONGES IN THE FORMULATION OF EXTENDED RELEASE TABLETS

Author:

Lakshmi S. Satya,P Jyothsna,Rao Y. Srinivasa,Mallikarjun P. Naga,

Abstract

Cyclodextrin has been recognized as a linker molecule that can link with the various drug substances to produce a nano-porous structure called nanosponges (NS) and increase the dissolution rate of poorly soluble drug substances. This work aimed to load rosuvastatin calcium (RSC) with solubility enhancer’s β-cyclodextrin (β-CD) or polyvinyl alcohol (PVA). β-CD based RSC-NS were fabricated by the emulsion solvent diffusion technique; with solubilizer dichloromethane and different ratios of ethyl cellulose as a co-polymer. Characterization of the prepared nanosponges was done by various testing procedures that confirm its nanosize and particle size and drug release. RSC loading in NS was assessed by DSC, FTIR and SEM. Among all the formulations F5 has 78.23 % entrapment efficiency. 2-3 folds of increased solubility were obtained with RSC-NS. F1-F6 formulations released 76.35 % - 98.69 % of the drug at the end of 30 min. In the preparation of extended-release tablets, NS prepared from F5 formulation was used and the best tablet formulation was selected based on various evaluation tests. All the formulations except S3, S8 followed first-order release kinetics. S1 & S2 drug release mechanism is Higuchi while other formulations are Korsemeyer-Peppas, so the release mechanism for most of the formulations is erosion than diffusion.

Publisher

Indian Drug Manufacturers' Association (IDMA)

Subject

Drug Discovery,Pharmaceutical Science,Pharmacology

Reference27 articles.

1. 1. WHO: Raised Cholesterol 2008, Available at http://www.who.int/gho/ncd/risk_factors/cholesterol_text/en/. Access Date- 7 January 2020.

2. 2. Ezallor-Rosuvastatin Calcium Tablets, Available at http://www.rxlist.com/ezallor-drug.htm#description. Access Date- 27 December 2019.

3. 3. Crestor Tablets –FDA, Available at http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/21366slr005lbl.pdf. Access Date- 2 January 2020.

4. 4. Satya Lakshmi S., Srinivasa Rao Y., Asha D., Kamala Kumari P. V. and Mallikarjun P. N.: Formulation and evaluation of rosuvastatin-calcium drug transdermal patch, Res. J. Pharm. Technol., 2020, 13, 4784-4790.

5. 5. Shen H. and Zhong M.: Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin, J. Pharm. Pharmacol., 2006, 58, 1183-1191.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3